Follow
Jonathan A Phillips
Jonathan A Phillips
Intellia Therapeutics, Vertex Pharmaceuticals, NASA Ames, Boehringer Ingelheim, University of
Verified email at intelliatx.com
Title
Cited by
Cited by
Year
CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis
JD Gillmore, E Gane, J Taubel, J Kao, M Fontana, ML Maitland, J Seitzer, ...
New England Journal of Medicine 385 (6), 493-502, 2021
13412021
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
F Dieterle, F Sistare, F Goodsaid, M Papaluca, JS Ozer, CP Webb, W Baer, ...
Nature biotechnology 28 (5), 455-462, 2010
4932010
Collagen gel contraction assay
P Ngo, P Ramalingam, JA Phillips, GT Furuta
Cell-Cell Interactions: Methods and Protocols, 103-109, 2006
2192006
Towards consensus practices to qualify safety biomarkers for use in early drug development
FD Sistare, F Dieterle, S Troth, DJ Holder, D Gerhold, ...
Nature biotechnology 28 (5), 446-454, 2010
1392010
Total-Body Irradiation of Postpubertal Mice with 137Cs Acutely Compromises the Microarchitecture of Cancellous Bone and Increases Osteoclasts
H Kondo, ND Searby, R Mojarrab, J Phillips, J Alwood, K Yumoto, ...
Radiation research 171 (3), 283-289, 2009
1312009
Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization
S Fowler, WLK Chen, DB Duignan, A Gupta, N Hariparsad, JR Kenny, ...
Lab on a Chip 20 (3), 446-467, 2020
912020
Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective
L Ewart, K Fabre, A Chakilam, Y Dragan, DB Duignan, J Eswaraka, J Gan, ...
Experimental Biology and Medicine 242 (16), 1579-1585, 2017
892017
Role for β1 integrins in cortical osteocytes during acute musculoskeletal disuse
JA Phillips, EAC Almeida, EL Hill, JI Aguirre, MF Rivera, I Nachbandi, ...
Matrix Biology 27 (7), 609-618, 2008
642008
A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies
JA Phillips, TSP Grandhi, M Davis, JC Gautier, N Hariparsad, D Keller, ...
Lab on a Chip 20 (3), 468-476, 2020
422020
Fibroblasts regulate contractile force independent of MMP activity in 3D-collagen
JA Phillips, CA Vacanti, LJ Bonassar
Biochemical and biophysical research communications 312 (3), 725-732, 2003
422003
Rat urinary osteopontin and neutrophil gelatinase-associated lipocalin improve certainty of detecting drug-induced kidney injury
JA Phillips, DJ Holder, D Ennulat, JC Gautier, JM Sauer, Y Yang, ...
Toxicological Sciences 151 (2), 214-223, 2016
402016
Matrix metalloproteinase activity synergizes with α2β1 integrins to enhance collagen remodeling
JA Phillips, LJ Bonassar
Experimental Cell Research 310 (1), 79-87, 2005
342005
Net reclassification index and integrated discrimination index are not appropriate for testing whether a biomarker improves predictive performance
PM Burch, WE Glaab, DJ Holder, JA Phillips, JM Sauer, EG Walker
Toxicological Sciences 156 (1), 11-13, 2017
312017
Crispr-Cas9
JD Gillmore, E Gane, J Taubel, J Kao, M Fontana, ML Maitland, J Seitzer, ...
vivo, 2021
292021
A predominant oxidative renal metabolite of empagliflozin in male mice is cytotoxic in mouse renal tubular cells but not genotoxic
JD Smith, Z Huang, PA Escobar, P Foppiano, H Maw, W Loging, H Yu, ...
International Journal of Toxicology 36 (6), 440-448, 2017
142017
Development of the gecko (Pachydactylus turneri) animal model during Foton M-2 to study comparative effects of microgravity in terrestrial and aquatic organisms
EA Almeida, C Roden, JA Phillips, RK Globus, N Searby, W Vercoutere, ...
Journal of Gravitational Physiology, Volume 13, No. 1, 2006
132006
Assessment of Inhibin B as a Biomarker of Testicular Injury Following Administration of Carbendazim, Cetrorelix, or 1, 2‐Dibromo‐3‐Chloropropane in Wistar Han Rats
JS Moffit, LS Her, AM Mineo, BL Knight, JA Phillips, MS Thibodeau
Birth Defects Research Part B: Developmental and Reproductive Toxicology 98 …, 2013
82013
Mode of action and human relevance assessment of male CD‐1 mouse renal adenocarcinoma associated with lifetime exposure to empagliflozin
JA Phillips, ME Taub, MS Bogdanffy, J Yuan, B Knight, JD Smith, WW Ku
Journal of Applied Toxicology 42 (10), 1570-1584, 2022
72022
Discovery and optimization of pyrazole amides as inhibitors of ELOVL1
JH Come, TJ Senter, MP Clark, JJ Court, Z Gale-Day, W Gu, E Krueger, ...
Journal of medicinal chemistry 64 (24), 17753-17776, 2021
72021
Pathogenesis of renal injury and gene expression changes in the male CD-1 mouse associated with exposure to Empagliflozin
B Knight, J Yuan, S Koegler, P Pande, J Hall, JD Hill, SE Hart, JA Phillips, ...
Toxicologic Pathology 46 (6), 671-682, 2018
72018
The system can't perform the operation now. Try again later.
Articles 1–20